Tamoxifen Citrate

Product NDC
71335-0893
11-digit product format
713350893
Labeler code
71335
Product ID
71335-0893_a4a8d2bc-8324-47a3-985b-114448547c7d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Tamoxifen Citrate
Dosage form
TABLET
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA074732
Marketing category
ANDA
Marketing start
2003-02-20
Marketing end
0000-00-00
Substance
TAMOXIFEN CITRATE
Active strength
20 mg/1
Pharmacologic classes
Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA]
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
71335-0893-17133508930130 TABLET in 1 BOTTLE (71335-0893-1) 30 tablet2018-07-060000-00-00NoNoCurrent
71335-0893-27133508930260 TABLET in 1 BOTTLE (71335-0893-2) 60 tablet2018-07-060000-00-00NoNoCurrent
71335-0893-37133508930390 TABLET in 1 BOTTLE (71335-0893-3) 90 tablet2018-07-060000-00-00NoNoCurrent
71335-0893-47133508930428 TABLET in 1 BOTTLE (71335-0893-4) 28 tablet2018-07-060000-00-00NoNoCurrent
71335-0893-57133508930558 TABLET in 1 BOTTLE (71335-0893-5) 58 tablet2018-07-060000-00-00NoNoCurrent
71335-0893-67133508930652 TABLET in 1 BOTTLE (71335-0893-6) 52 tablet2018-07-060000-00-00NoNoCurrent